A recent clinical study from our team demonstrated that LRP-1 expression was significantly lower in colon adenocarcinoma cells compared to colon epithelial cells and stromal cells and that this decrease in LRP-1 expression is associated with worse patient outcomes (Boulagnon-Rombi et al., 2018). The gene discussed is LRP1; the disease is colon adenocarcinoma.